Grandjean, J., Desrosiers-Gregoire, G., Anckaerts, C. et al.

N. Falgàs, M. Peña-González, A. Val-Guardiola, A. Pérez-Millan, N. Guillén, J. Sarto, D. Esteller, B. Bosch, G. Fernández-Villullas, A. Tort-Merino, G. Mayà, J. M. Augé, A. Iranzo, M. Balasa, A. Lladó, M. Morales-Ruiz, N. Bargalló, E. Muñoz-Moreno, L. T. Grinberg, R. Sánchez-Valle

Gisela Sugranyes, Elena de la Serna, Daniel Ilzarbe, Jose Carlos Pariente, Roger Borras, Soledad Romero, Mireia Rosa, Inmaculada Baeza, Maria Dolores Moreno, Miguel Bernardo, Eduard Vieta, Josefina Castro-Fornieles

Carlos Laredo, Yashu Zhao, Salvatore Rudilosso, Arturo Renú, José Carlos Pariente, Ángel Chamorro, Xabier Urra

Christopher D Whelan, Andre Altmann, et al.

Sara Fernández-García, Sara Conde-Berriozabal, Esther García-García, Clara Gort-Paniello, David Bernal-Casas, Gerardo García-Díaz Barriga, Javier López-Gil, Emma Muñoz-Moreno, Guadalupe Soria, Leticia Campa, Francesc Artigas, Manuel José Rodríguez, Jordi Alberch, Mercè Masana

Emma Muñoz-Moreno, Raúl Tudela, Xavier López-Gil, Guadalupe Soria

Vision & Mission: All Medical Practice Based on Scientific Evidence ECRIN's vision is to generate scientific evidence to optimise medical practice. To achieve this vision, ECRIN supports the conduct of multinational clinical research in Europe (i.e. its vision). By managing and supporting clinical trials across borders, connecting networks, and advising and implementing policy, ECRIN advances knowledge flow, competitiveness and integration in European clinical research.

European infrastructure for translational medicine. We pool resources and services for research communities to translate scientific discoveries into benefits for patients.

EBRAINS is a new digital research infrastructure, created by the EU-funded Human Brain Project, that collects a wide range of data and tools for brain-related research. EBRAINS will take advantage of the work done by the Human Brain Project teams in digital neuroscience, brain medicine and brain-inspired technology and take it to the next level.

The mission is to improve the lives of people affected by inflammatory bowel disease (IBD), promoting care, teaching, research excellence and influencing political and social actions.

Mission: Promotion of excellence in cancer research in Spain, as well as the incorporation of new findings into clinical practice.

Mission: to develop cooperative actions of excellence in the double field of translational cardiovascular research and training. These actions are aimed at the exploitation, attraction and retention of talent, and must lead to the clarification of the mechanisms of cardiovascular disease and the benefits that can be transferred to the diagnosis, prevention, cure or palliation of talent. 'this pathology and its sequelae. They must also contribute to the prosperity of our society, helping to protect the health of our citizens, contributing to the generation of employment and supporting the development of the biomedical industry within our borders.

Mission: Lead the research effort of excellence in diabetes and associated metabolic diseases, as well as accelerate the translation of scientific results into clinical practice to improve the health of the population and people with diabetes and metabolic diseases.

Mission: combating respiratory diseases by encouraging research excellence and translating it quickly and safely into clinical practice.

SEFALer is a service coordinated by CIBERER through various research groups, unprecedented at the national level and specialized in the phenotyping of animal models with specific application for rare diseases. The Networked Laboratory Animal Phenotyping Service (SEFALer) is integrated into the structure of CIBERER. Research is the basis for providing new tools for the diagnosis and therapy of rare diseases, in this context, the development and study of animal models of human disease plays a central role. Characterization of the phenotype of rare disease animal models contributes to the study of pathophysiology, to the understanding of the underlying molecular mechanisms, to the identification of diagnostic criteria, and to the evaluation and refinement of new therapies. Because most rare diseases have a complex syndromic nature, it is necessary to offer a range of specialized tests capable of assessing the functioning of different organs.

Mission: Our mission is to be a center where collaboration and cooperation between biomedical and clinical research groups prevail and are favored, with special emphasis on the aspects of genetic, molecular, biochemical and cell research. of rare, genetic or acquired diseases. The aim is to improve our knowledge of the epidemiology, causes and production mechanisms of rare diseases. This research is the basis for providing new tools for the diagnosis and therapy of rare diseases, encouraging translational or translational research between the scientific environment of the laboratory and the clinical environment of health centers.

The main objective of the Bioinformatics Platform is to create a collaborative environment within the Center for Biomedical Research in Liver and Digestive Diseases (CIBEREHD) and to contribute to research projects that support scientists and institutions in the computing and statistics of your projects. We have extensive experience in biological research fields that require the latest computational techniques.

Provide world-class basic bioinformatics resources to the national and international life sciences research community in key fields such as functional genomics, RNA-Seq transcriptomics, genotyping, genomic medicine, and molecular dynamics simulations. Provide a platform for integrated basic bioinformatics services to the research community. Facilitate the coordinated participation of bioinformatics groups in large-scale national and international projects that require and benefit from closely collaborating teams that are known and accustomed to working together.

SCReN: Support for multicenter clinical trials Achieve an advanced level of technical competence in the processes related to the development and management of clinical research, ensure compliance with legal requirements and the competence of researchers participating in platform studies on methodological aspects and PCBs. others.

BioCores is a directory of basic facilities, technology platforms and scientific services currently in Spain. BioCores offers a tool to find a wide range of cutting-edge, state-of-the-art scientific services, techniques and equipment, to support both biomedical and life sciences research and the scientific community.

The BCTP has as its great challenge to advance the arrival of innovative treatments to patients in Catalonia. BCTP needs to improve the coordination, integration, quality, inclusiveness and speed of clinical research. This will be thanks to the optimization and homogenization of the clinical research processes of its members, as well as the human and technological potential of the centers. In addition, the BCTP will function as a dissemination platform to attract new studies from outside Catalonia.

Bioinformatics Barcelona (BIB) is an association for the provision of education and training, the promotion of advanced research, the transfer of knowledge and technology, the stimulation of competitiveness and innovation in the industrial sector, and the provision of 'greater visibility as an international entity. BIB was born to cover the need to generate synergies between biology and computer science, for a stronger union between these areas and for the development of high quality education and training programs in the creation of bioinformatics talent.